Ki-67 staining is commonly used in the evaluation of various cancers, including breast cancer, prostate cancer, lymphomas, and neuroendocrine tumors. In breast cancer, for instance, the Ki-67 index is part of the routine assessment and helps guide treatment decisions. In lymphomas, it helps differentiate between indolent and aggressive forms, while in neuroendocrine tumors, it aids in grading the tumor.